AFT Pharmaceuticals considers IPO, listing on NZX and ASX as it eyes international sales

AFT Pharmaceuticals considers IPO, listing on NZX and ASX as it eyes international sales
Sophie Boot
By Sophie Boot Nov. 17 (BusinessDesk) - AFT Pharmaceuticals, the Auckland-based pharmaceutical company, is considering a $49 million initial public offering along with listing on the NZX and ASX. The proposed offer involves a primary raise of $45 million, and a $4 million selldown by the Atkinson Family Trust, which owns 87 percent of the company. AFT, which was founded in 1997, made a loss of $12.9 million for the year ended March 31, on revenue of $56.2 million. The company has achieved a compound annual growth rate in operating reve...